Humana — Oct 30, 2024 release

Full Year 2024 Projections - As of October 30, 2024 Current Guidance Prior Guidance Diluted earnings per common share GAAP: at least $12.89 GAAP: approximately $12.81 Non-GAAP: at least $16.00 Non-GAAP: approximately $16.00 Total Revenues Consolidated no change GAAP: approximately $116 billion Consolidated and segment level revenue projections include expected investment income. Segment level revenues include amounts that eliminate in consolidation. Insurance segment no change GAAP: approximately $112 billion CenterWell segment no change GAAP: approximately $19 billion Change in year-end medical membership from prior year-end Individual Medicare Advantage Growth of approximately 265,000 Growth of approximately 225,000 Group Medicare Advantage Growth of approximately 35,000 Growth of approximately 45,000 Medicare stand-alone PDP no change Decline of approximately 600,000 State-based contracts Growth of approximately 200,000 Growth of approximately 250,000 State-based contracts guidance includes membership in Florida, Illinois, Indiana, Kentucky, Louisiana, Ohio, Oklahoma, South Carolina, and Wisconsin. Benefit Ratio  Insurance segment no change GAAP: approximately 90% Ratio calculation: benefits expense as a percent of premiums revenues. Operating Cost Ratio Consolidated no change GAAP: approximately 11.4% Ratio calculation: operating costs excluding depreciation and amortization as a percent of revenues excluding investment income. Segme